HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Namiki Izumi Selected Research

Creatinine

11/2016Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.
6/2016Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites.
6/2015Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial.
3/2013Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated-interferon plus ribavirin therapy for chronic hepatitis C.
9/2011Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Namiki Izumi Research Topics

Disease

118Hepatocellular Carcinoma (Hepatoma)
03/2024 - 11/2003
68Chronic Hepatitis C
04/2024 - 04/2003
52Infections
08/2023 - 10/2003
45Fibrosis (Cirrhosis)
04/2024 - 12/2003
25Liver Cirrhosis (Hepatic Cirrhosis)
04/2024 - 09/2007
25Neoplasms (Cancer)
01/2023 - 11/2005
24Chronic Hepatitis B
10/2023 - 12/2003
23Hepatitis C
01/2022 - 09/2003
17Liver Diseases (Liver Disease)
02/2024 - 01/2005
10Disease Progression
05/2022 - 01/2003
8Hepatitis B
03/2023 - 01/2011
8Thrombocytopenia (Thrombopenia)
10/2020 - 09/2011
7Chronic Hepatitis (Chronic Active Hepatitis)
04/2024 - 01/2003
7Hepatitis
01/2023 - 01/2003
7Ascites
06/2022 - 02/2015
6Liver Neoplasms (Liver Cancer)
03/2023 - 01/2013
4Non-alcoholic Fatty Liver Disease
09/2023 - 12/2019
4Carcinogenesis
03/2023 - 01/2017
4Fatty Liver
01/2023 - 08/2010
4Neoplasm Metastasis (Metastasis)
07/2022 - 08/2012
4COVID-19
01/2022 - 01/2020
4Hemorrhage
04/2021 - 01/2016
4Thrombosis (Thrombus)
10/2020 - 02/2018
4Anemia
10/2020 - 09/2011
4Headache (Headaches)
11/2016 - 06/2014
3Viremia
08/2023 - 10/2018
3Cholangiocarcinoma
07/2023 - 08/2021
3Neutropenia
10/2020 - 03/2015
3Nasopharyngitis
11/2016 - 06/2014
2Hypertension (High Blood Pressure)
04/2024 - 01/2018
2Weight Loss (Weight Reduction)
01/2022 - 01/2017
2Pneumonia (Pneumonitis)
01/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

52InterferonsIBA
08/2022 - 09/2003
47Ribavirin (Virazole)FDA LinkGeneric
10/2019 - 04/2003
34Antiviral Agents (Antivirals)IBA
10/2023 - 01/2008
26Sorafenib (BAY 43-9006)FDA Link
11/2022 - 09/2010
14Biomarkers (Surrogate Marker)IBA
12/2023 - 06/2006
14alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2023 - 01/2006
13DNA (Deoxyribonucleic Acid)IBA
08/2023 - 12/2003
12Alanine Transaminase (SGPT)IBA
09/2023 - 01/2006
12AlbuminsIBA
11/2022 - 09/2011
11lenvatinibIBA
06/2023 - 06/2019
10tenofovir alafenamideIBA
10/2023 - 11/2016
9Hepatitis B e AntigensIBA
08/2023 - 12/2003
9wisteria lectinIBA
10/2021 - 09/2015
8BilirubinIBA
01/2023 - 07/2009
8Fetal Proteins (Fetoprotein)IBA
11/2022 - 01/2011
8SofosbuvirIBA
10/2022 - 11/2014
8RNA (Ribonucleic Acid)IBA
01/2022 - 01/2010
7Bevacizumab (Avastin)FDA Link
03/2024 - 01/2022
7atezolizumabIBA
03/2024 - 01/2022
7Tenofovir (Viread)FDA Link
10/2023 - 11/2016
7NucleosidesIBA
01/2023 - 01/2005
7NucleotidesIBA
01/2023 - 06/2015
7Carrier Proteins (Binding Protein)IBA
10/2021 - 12/2018
7Proteins (Proteins, Gene)FDA Link
10/2019 - 11/2005
6AntigensIBA
10/2021 - 09/2002
6lusutrombopagIBA
04/2021 - 01/2019
6Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2018 - 01/2010
6SimeprevirIBA
12/2015 - 05/2014
6Interferon-alpha (Interferon Alfa)IBA
03/2013 - 01/2003
5entecavirFDA Link
08/2023 - 01/2010
5acarboxyprothrombin (PIVKA)IBA
01/2023 - 04/2012
5daclatasvirIBA
05/2022 - 01/2014
5TolvaptanFDA Link
01/2022 - 01/2016
5Transaminases (Aminotransferases)IBA
01/2018 - 01/2006
5CreatinineIBA
11/2016 - 09/2011
4Therapeutic UsesIBA
04/2023 - 01/2010
4Serum AlbuminIBA
11/2022 - 10/2013
4asunaprevirIBA
05/2022 - 06/2014
4Hepatitis B Surface Antigens (HBsAg)FDA Link
06/2020 - 02/2014
4Tumor Biomarkers (Tumor Markers)IBA
10/2019 - 11/2005
4Amino AcidsFDA Link
01/2017 - 12/2010
4Lamivudine (Epivir)FDA Link
02/2010 - 12/2003
3omega-Chloroacetophenone (Mace)IBA
04/2024 - 01/2022
3glecaprevir and pibrentasvirIBA
04/2024 - 07/2019
3velpatasvirIBA
10/2022 - 07/2018
3Tyrosine Kinase InhibitorsIBA
05/2022 - 08/2019
3DiureticsIBA
01/2022 - 06/2016
3Carnitine (L-Carnitine)FDA LinkGeneric
11/2020 - 08/2015
3SonazoidIBA
07/2019 - 01/2014
3CollagenIBA
01/2019 - 06/2013
3Messenger RNA (mRNA)IBA
01/2017 - 09/2003
2Protons (Proton)IBA
12/2023 - 10/2023
2BezafibrateIBA
09/2023 - 08/2004
2HLA-A Antigens (HLA-A)IBA
03/2023 - 01/2018
2HLA Antigens (Human Leukocyte Antigens)IBA
03/2023 - 01/2014
2Vasopressins (Vasopressin)IBA
01/2022 - 06/2016
2Prothrombin (Factor II)IBA
01/2022 - 01/2011
2Immunoglobulin G (IgG)IBA
01/2021 - 01/2020
2Indicators and Reagents (Reagents)IBA
01/2021 - 02/2018

Therapy/Procedure

115Therapeutics
04/2024 - 01/2003
12Radiofrequency Ablation
06/2022 - 09/2007
6Drug Therapy (Chemotherapy)
07/2022 - 01/2018
5Aftercare (After-Treatment)
01/2022 - 08/2014
5Platelet Transfusion (Blood Platelet Transfusions)
04/2021 - 01/2018
5Liver Transplantation
07/2016 - 09/2007
4Hepatectomy
01/2022 - 01/2020
4Renal Dialysis (Hemodialysis)
07/2019 - 12/2015
3Drug Tapering
09/2011 - 01/2011